These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3984398)

  • 1. [Prognosis and indications of corticosteroid treatment of intrathoracic sarcoidosis--conclusions from a prospective study].
    Eule H; Roth I; Weinecke A; Wuthe H
    Z Erkr Atmungsorgane; 1985; 164(1):43-59. PubMed ID: 3984398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid therapy of pulmonary sarcoidosis. A prospective evaluation of alternate day and daily dosage in stage II disease.
    Selroos O; Sellergren TL
    Scand J Respir Dis; 1979 Aug; 60(4):215-21. PubMed ID: 531541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid therapy of intrathoracic sarcoidosis stages I and II--results of a controlled clinical trial.
    Eule H; Roth I; Ehrke I; Weinecke W
    Z Erkr Atmungsorgane; 1977 Jul; 149(1):142-7. PubMed ID: 343403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that steroids alter the natural history of previously untreated progressive pulmonary sarcoidosis.
    Odlum CM; FitzGerald MX
    Sarcoidosis; 1986 Mar; 3(1):40-6. PubMed ID: 3575916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy.
    Prior C; Haslam PL
    Am Rev Respir Dis; 1991 Jan; 143(1):53-60. PubMed ID: 1898846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
    Rizzato G; Riboldi A; Imbimbo B; Torresin A; Milani S
    Respir Med; 1997 Sep; 91(8):449-60. PubMed ID: 9338047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis.
    Laviolette M; La Forge J; Tennina S; Boulet LP
    Chest; 1991 Aug; 100(2):380-4. PubMed ID: 1864110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended experience in the long-term corticosteroid treatment of pulmonary sarcoidosis.
    Johns CJ; Macgregor MI; Zachary JB; Ball WC
    Ann N Y Acad Sci; 1976; 278():722-31. PubMed ID: 1067052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial chitotriosidase measurements in sarcoidosis--two to five year follow-up study.
    Harlander M; Salobir B; Zupančič M; Dolenšek M; Bavčar Vodovnik T; Terčelj M
    Respir Med; 2014 May; 108(5):775-82. PubMed ID: 24594143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis for sarcoidosis in a defined geographical area.
    Huhti E; Poukkula A; Lilja M
    Br J Dis Chest; 1987 Oct; 81(4):381-90. PubMed ID: 3449122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A ten-year study of sarcoidosis.
    Bunn DT; Johnston RN
    Br J Dis Chest; 1972 Jan; 66(1):45-52. PubMed ID: 5017932
    [No Abstract]   [Full Text] [Related]  

  • 12. A ten-year study of corticosteroid treatment of pulmonary sarcoidosis.
    Johns CJ; Zachary JB; Ball WC
    Johns Hopkins Med J; 1974 May; 134(5):271-83. PubMed ID: 4826124
    [No Abstract]   [Full Text] [Related]  

  • 13. Two asymptomatic cases with sarcoidosis demonstrated sequential evolution from radiographic stage I to III within five years.
    Ishioka S; Maeda A; Hiyama K; Jougasaki Y; Yamakido M
    Hiroshima J Med Sci; 1999 Sep; 48(3):101-3. PubMed ID: 10598414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The decrement of diffusing capacity observed by corticosteroid therapy in sarcoidosis (author's transl)].
    Araki T; Matsuoka R; Okazaki N; Hara H; Kuratomi Y; Natori H; Arai T; Kita S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Nov; 18(11):809-14. PubMed ID: 7289244
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum angiotensin convertase activity and clinical course in sarcoidosis. Course studies in primary chronic sarcoidosis].
    Sehrt I; Christ R
    Z Erkr Atmungsorgane; 1984; 163(2):175-86. PubMed ID: 6095546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cavitary pulmonary sarcoidosis.
    Dauber JH; Kaufman JH; Beswick DR; Rossman MD
    Arch Intern Med; 1983 May; 143(5):1058-9. PubMed ID: 6679219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.
    Goldstein DS; Williams MH
    Thorax; 1986 Jun; 41(6):473-4. PubMed ID: 3787523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erster Bericht über eine kontrollierte klinische Untersuchung zur Prednisolon-Behandlung der thorakalen Sarkoidose].
    Roth I; Ehrke I; Eule H; Weinecke W
    Z Erkr Atmungsorgane; 1975 Jan; 142(1):49-58. PubMed ID: 818827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [X-ray, laboratory, and functional parallels in intrathoracic sarcoidosis].
    Vizel IY; Vizel AA; Shaimuratov RI
    Ter Arkh; 2015; 87(3):48-52. PubMed ID: 26027240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of the treatment of patients with atypical sarcoidosis of the respiratory organs].
    Teriaeva MV
    Probl Tuberk; 1990; (12):30-3. PubMed ID: 2084689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.